Reduced 11β-Hydroxysteroid Dehydrogenase Activity in the Remaining Kidney Following Nephrectomy

Abstract Intracellular access of steroids to gluco- and mineralocorticoid receptors is regulated by reduced 11β-hydroxysteroid dehydrogenase (OHSD) 1 and 2. These enzymes convert active 11β-OH-steroids into inactive 11-keto-steroids. The purpose of the present study was to establish whether the 11β-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrinology (Philadelphia) 1998-04, Vol.139 (4), p.1533-1539
Hauptverfasser: Escher, Geneviève, Vogt, Bruno, Beck, Thomas, Guntern, Daniel, Frey, Brigitte M., Frey, Felix J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1539
container_issue 4
container_start_page 1533
container_title Endocrinology (Philadelphia)
container_volume 139
creator Escher, Geneviève
Vogt, Bruno
Beck, Thomas
Guntern, Daniel
Frey, Brigitte M.
Frey, Felix J.
description Abstract Intracellular access of steroids to gluco- and mineralocorticoid receptors is regulated by reduced 11β-hydroxysteroid dehydrogenase (OHSD) 1 and 2. These enzymes convert active 11β-OH-steroids into inactive 11-keto-steroids. The purpose of the present study was to establish whether the 11β-OHSD1 and 11β-OHSD2 are modulated in the remnant kidney 24 h or 14 days after uninephrectomy (UNX) in rats. Overall, 11β-OHSD activity was analyzed by measuring the ratio of the exogenous 11β-OH-steroid prednisolone to its 11-keto metabolite prednisone in vivo in kidney tissue using high performance liquid chromatography. To determine which isoenzyme accounts for the changed activity 24 h after UNX, the oxidation and reduction attributable to 11β-OHSD1 and oxidation to 11β-OHSD2 were analyzed in total renal extracts and in isolated glomeruli, proximal convoluted tubules (PCT), cortical ascending limbs, and cortical convoluted tubules (CCT). The messenger RNA content of 11β-OHSD1 and 11β-OHSD2 was measured by RT-PCR in renal tissues and single segments, using glyceraldehyde-3-phosphate-dehydrogenase as an internal standard. Protein amounts of 11β-OHSD1 and 11β-OHSD2 were assessed by Western blot. The prednisolone/prednisone ratio increased 24 h after UNX in 9 out of 10 animals (P ≤ 0.0011), and was unchanged 14 days after UNX. 11β-OHSD1 oxidation (P ≤ 0.032) and reduction activity (P ≤ 0.002) declined 24 h after UNX in total extracts. 11β-OHSD1 oxidase activity was more than 3 times higher in PCT than in glomeruli, cortical ascending limbs, and CCT, and declined by 50% after UNX (P ≤ 0.001). The reductase activity did not change following UNX in PCT. 11β-OHSD2 activity was 5–15 times higher in CCT than in the other segments, and decreased significantly after UNX (P ≤ 0.008). UNX did not affect messenger RNA and protein levels of both enzymes in total renal extracts. In conclusion, 11β-OHSD1 and 11β-OHSD2 are predominantly expressed in PCT and CCT, respectively, and their corresponding oxidative activities decline after UNX. Thus, the access of 11β-glucocorticosteroids to gluco- and mineralocorticoid receptors in the remaining kidney is facilitated after UNX.
doi_str_mv 10.1210/endo.139.4.5891
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3130506370</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/endo.139.4.5891</oup_id><sourcerecordid>3130506370</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2581-f3c5e8d78e8beb2440b17426a69fd4b2e43562c94bdbf7144951819f5b50920f3</originalsourceid><addsrcrecordid>eNqFkM1OwzAQhC0EEqVw5mqJG1JS_8bxsQJKERVIFZxNEm9aV21cnATIa_EgPBOJyp3Takczu6MPoUtKYsoomUBlfUy5jkUsU02P0IhqISNFFTlGI0IojxRj6hSd1fWmX4UQfITelmDbAiym9Oc7mnc2-K-ubiB4Z_EtrAdhBVVWA54WjftwTYddhZs14CXsMle5aoUfna2gwzO_3frPQXiC_TpA0fhdd45Oymxbw8XfHKPX2d3LzTxaPN8_3EwXUcFkSqOSFxJSq1JIc8iZECSnSrAkS3RpRc5AcJmwQovc5qXqy2tJU6pLmUuiGSn5GF0d7u6Df2-hbszGt6HqXxpOOZEk4Yr0rsnBVQRf1wFKsw9ul4XOUGIGjGbAaHqMRpgBY5-4PiR8u__X_AvwrnSn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130506370</pqid></control><display><type>article</type><title>Reduced 11β-Hydroxysteroid Dehydrogenase Activity in the Remaining Kidney Following Nephrectomy</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Escher, Geneviève ; Vogt, Bruno ; Beck, Thomas ; Guntern, Daniel ; Frey, Brigitte M. ; Frey, Felix J.</creator><creatorcontrib>Escher, Geneviève ; Vogt, Bruno ; Beck, Thomas ; Guntern, Daniel ; Frey, Brigitte M. ; Frey, Felix J.</creatorcontrib><description>Abstract Intracellular access of steroids to gluco- and mineralocorticoid receptors is regulated by reduced 11β-hydroxysteroid dehydrogenase (OHSD) 1 and 2. These enzymes convert active 11β-OH-steroids into inactive 11-keto-steroids. The purpose of the present study was to establish whether the 11β-OHSD1 and 11β-OHSD2 are modulated in the remnant kidney 24 h or 14 days after uninephrectomy (UNX) in rats. Overall, 11β-OHSD activity was analyzed by measuring the ratio of the exogenous 11β-OH-steroid prednisolone to its 11-keto metabolite prednisone in vivo in kidney tissue using high performance liquid chromatography. To determine which isoenzyme accounts for the changed activity 24 h after UNX, the oxidation and reduction attributable to 11β-OHSD1 and oxidation to 11β-OHSD2 were analyzed in total renal extracts and in isolated glomeruli, proximal convoluted tubules (PCT), cortical ascending limbs, and cortical convoluted tubules (CCT). The messenger RNA content of 11β-OHSD1 and 11β-OHSD2 was measured by RT-PCR in renal tissues and single segments, using glyceraldehyde-3-phosphate-dehydrogenase as an internal standard. Protein amounts of 11β-OHSD1 and 11β-OHSD2 were assessed by Western blot. The prednisolone/prednisone ratio increased 24 h after UNX in 9 out of 10 animals (P ≤ 0.0011), and was unchanged 14 days after UNX. 11β-OHSD1 oxidation (P ≤ 0.032) and reduction activity (P ≤ 0.002) declined 24 h after UNX in total extracts. 11β-OHSD1 oxidase activity was more than 3 times higher in PCT than in glomeruli, cortical ascending limbs, and CCT, and declined by 50% after UNX (P ≤ 0.001). The reductase activity did not change following UNX in PCT. 11β-OHSD2 activity was 5–15 times higher in CCT than in the other segments, and decreased significantly after UNX (P ≤ 0.008). UNX did not affect messenger RNA and protein levels of both enzymes in total renal extracts. In conclusion, 11β-OHSD1 and 11β-OHSD2 are predominantly expressed in PCT and CCT, respectively, and their corresponding oxidative activities decline after UNX. Thus, the access of 11β-glucocorticosteroids to gluco- and mineralocorticoid receptors in the remaining kidney is facilitated after UNX.</description><identifier>ISSN: 0013-7227</identifier><identifier>EISSN: 1945-7170</identifier><identifier>DOI: 10.1210/endo.139.4.5891</identifier><language>eng</language><publisher>Washington: Oxford University Press</publisher><subject>11β-Hydroxysteroid dehydrogenase ; Dehydrogenase ; Dehydrogenases ; Enzymes ; Glomerulus ; Glucocorticoids ; Glyceraldehyde ; High performance liquid chromatography ; Hydroxysteroids ; In vivo methods and tests ; Kidneys ; Limbs ; Liquid chromatography ; Metabolites ; Mineralocorticoid receptors ; mRNA ; Nephrectomy ; Oxidation ; Prednisolone ; Prednisone ; Proteins ; Proximal tubules ; Receptors ; Reductases ; Segments ; Steroid hormones ; Steroids ; Tubules</subject><ispartof>Endocrinology (Philadelphia), 1998-04, Vol.139 (4), p.1533-1539</ispartof><rights>Copyright © 1998 by The Endocrine Society 1998</rights><rights>Copyright © 1998 by The Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2581-f3c5e8d78e8beb2440b17426a69fd4b2e43562c94bdbf7144951819f5b50920f3</citedby><cites>FETCH-LOGICAL-c2581-f3c5e8d78e8beb2440b17426a69fd4b2e43562c94bdbf7144951819f5b50920f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Escher, Geneviève</creatorcontrib><creatorcontrib>Vogt, Bruno</creatorcontrib><creatorcontrib>Beck, Thomas</creatorcontrib><creatorcontrib>Guntern, Daniel</creatorcontrib><creatorcontrib>Frey, Brigitte M.</creatorcontrib><creatorcontrib>Frey, Felix J.</creatorcontrib><title>Reduced 11β-Hydroxysteroid Dehydrogenase Activity in the Remaining Kidney Following Nephrectomy</title><title>Endocrinology (Philadelphia)</title><description>Abstract Intracellular access of steroids to gluco- and mineralocorticoid receptors is regulated by reduced 11β-hydroxysteroid dehydrogenase (OHSD) 1 and 2. These enzymes convert active 11β-OH-steroids into inactive 11-keto-steroids. The purpose of the present study was to establish whether the 11β-OHSD1 and 11β-OHSD2 are modulated in the remnant kidney 24 h or 14 days after uninephrectomy (UNX) in rats. Overall, 11β-OHSD activity was analyzed by measuring the ratio of the exogenous 11β-OH-steroid prednisolone to its 11-keto metabolite prednisone in vivo in kidney tissue using high performance liquid chromatography. To determine which isoenzyme accounts for the changed activity 24 h after UNX, the oxidation and reduction attributable to 11β-OHSD1 and oxidation to 11β-OHSD2 were analyzed in total renal extracts and in isolated glomeruli, proximal convoluted tubules (PCT), cortical ascending limbs, and cortical convoluted tubules (CCT). The messenger RNA content of 11β-OHSD1 and 11β-OHSD2 was measured by RT-PCR in renal tissues and single segments, using glyceraldehyde-3-phosphate-dehydrogenase as an internal standard. Protein amounts of 11β-OHSD1 and 11β-OHSD2 were assessed by Western blot. The prednisolone/prednisone ratio increased 24 h after UNX in 9 out of 10 animals (P ≤ 0.0011), and was unchanged 14 days after UNX. 11β-OHSD1 oxidation (P ≤ 0.032) and reduction activity (P ≤ 0.002) declined 24 h after UNX in total extracts. 11β-OHSD1 oxidase activity was more than 3 times higher in PCT than in glomeruli, cortical ascending limbs, and CCT, and declined by 50% after UNX (P ≤ 0.001). The reductase activity did not change following UNX in PCT. 11β-OHSD2 activity was 5–15 times higher in CCT than in the other segments, and decreased significantly after UNX (P ≤ 0.008). UNX did not affect messenger RNA and protein levels of both enzymes in total renal extracts. In conclusion, 11β-OHSD1 and 11β-OHSD2 are predominantly expressed in PCT and CCT, respectively, and their corresponding oxidative activities decline after UNX. Thus, the access of 11β-glucocorticosteroids to gluco- and mineralocorticoid receptors in the remaining kidney is facilitated after UNX.</description><subject>11β-Hydroxysteroid dehydrogenase</subject><subject>Dehydrogenase</subject><subject>Dehydrogenases</subject><subject>Enzymes</subject><subject>Glomerulus</subject><subject>Glucocorticoids</subject><subject>Glyceraldehyde</subject><subject>High performance liquid chromatography</subject><subject>Hydroxysteroids</subject><subject>In vivo methods and tests</subject><subject>Kidneys</subject><subject>Limbs</subject><subject>Liquid chromatography</subject><subject>Metabolites</subject><subject>Mineralocorticoid receptors</subject><subject>mRNA</subject><subject>Nephrectomy</subject><subject>Oxidation</subject><subject>Prednisolone</subject><subject>Prednisone</subject><subject>Proteins</subject><subject>Proximal tubules</subject><subject>Receptors</subject><subject>Reductases</subject><subject>Segments</subject><subject>Steroid hormones</subject><subject>Steroids</subject><subject>Tubules</subject><issn>0013-7227</issn><issn>1945-7170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkM1OwzAQhC0EEqVw5mqJG1JS_8bxsQJKERVIFZxNEm9aV21cnATIa_EgPBOJyp3Takczu6MPoUtKYsoomUBlfUy5jkUsU02P0IhqISNFFTlGI0IojxRj6hSd1fWmX4UQfITelmDbAiym9Oc7mnc2-K-ubiB4Z_EtrAdhBVVWA54WjftwTYddhZs14CXsMle5aoUfna2gwzO_3frPQXiC_TpA0fhdd45Oymxbw8XfHKPX2d3LzTxaPN8_3EwXUcFkSqOSFxJSq1JIc8iZECSnSrAkS3RpRc5AcJmwQovc5qXqy2tJU6pLmUuiGSn5GF0d7u6Df2-hbszGt6HqXxpOOZEk4Yr0rsnBVQRf1wFKsw9ul4XOUGIGjGbAaHqMRpgBY5-4PiR8u__X_AvwrnSn</recordid><startdate>19980401</startdate><enddate>19980401</enddate><creator>Escher, Geneviève</creator><creator>Vogt, Bruno</creator><creator>Beck, Thomas</creator><creator>Guntern, Daniel</creator><creator>Frey, Brigitte M.</creator><creator>Frey, Felix J.</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope></search><sort><creationdate>19980401</creationdate><title>Reduced 11β-Hydroxysteroid Dehydrogenase Activity in the Remaining Kidney Following Nephrectomy</title><author>Escher, Geneviève ; Vogt, Bruno ; Beck, Thomas ; Guntern, Daniel ; Frey, Brigitte M. ; Frey, Felix J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2581-f3c5e8d78e8beb2440b17426a69fd4b2e43562c94bdbf7144951819f5b50920f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>11β-Hydroxysteroid dehydrogenase</topic><topic>Dehydrogenase</topic><topic>Dehydrogenases</topic><topic>Enzymes</topic><topic>Glomerulus</topic><topic>Glucocorticoids</topic><topic>Glyceraldehyde</topic><topic>High performance liquid chromatography</topic><topic>Hydroxysteroids</topic><topic>In vivo methods and tests</topic><topic>Kidneys</topic><topic>Limbs</topic><topic>Liquid chromatography</topic><topic>Metabolites</topic><topic>Mineralocorticoid receptors</topic><topic>mRNA</topic><topic>Nephrectomy</topic><topic>Oxidation</topic><topic>Prednisolone</topic><topic>Prednisone</topic><topic>Proteins</topic><topic>Proximal tubules</topic><topic>Receptors</topic><topic>Reductases</topic><topic>Segments</topic><topic>Steroid hormones</topic><topic>Steroids</topic><topic>Tubules</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Escher, Geneviève</creatorcontrib><creatorcontrib>Vogt, Bruno</creatorcontrib><creatorcontrib>Beck, Thomas</creatorcontrib><creatorcontrib>Guntern, Daniel</creatorcontrib><creatorcontrib>Frey, Brigitte M.</creatorcontrib><creatorcontrib>Frey, Felix J.</creatorcontrib><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Endocrinology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Escher, Geneviève</au><au>Vogt, Bruno</au><au>Beck, Thomas</au><au>Guntern, Daniel</au><au>Frey, Brigitte M.</au><au>Frey, Felix J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced 11β-Hydroxysteroid Dehydrogenase Activity in the Remaining Kidney Following Nephrectomy</atitle><jtitle>Endocrinology (Philadelphia)</jtitle><date>1998-04-01</date><risdate>1998</risdate><volume>139</volume><issue>4</issue><spage>1533</spage><epage>1539</epage><pages>1533-1539</pages><issn>0013-7227</issn><eissn>1945-7170</eissn><abstract>Abstract Intracellular access of steroids to gluco- and mineralocorticoid receptors is regulated by reduced 11β-hydroxysteroid dehydrogenase (OHSD) 1 and 2. These enzymes convert active 11β-OH-steroids into inactive 11-keto-steroids. The purpose of the present study was to establish whether the 11β-OHSD1 and 11β-OHSD2 are modulated in the remnant kidney 24 h or 14 days after uninephrectomy (UNX) in rats. Overall, 11β-OHSD activity was analyzed by measuring the ratio of the exogenous 11β-OH-steroid prednisolone to its 11-keto metabolite prednisone in vivo in kidney tissue using high performance liquid chromatography. To determine which isoenzyme accounts for the changed activity 24 h after UNX, the oxidation and reduction attributable to 11β-OHSD1 and oxidation to 11β-OHSD2 were analyzed in total renal extracts and in isolated glomeruli, proximal convoluted tubules (PCT), cortical ascending limbs, and cortical convoluted tubules (CCT). The messenger RNA content of 11β-OHSD1 and 11β-OHSD2 was measured by RT-PCR in renal tissues and single segments, using glyceraldehyde-3-phosphate-dehydrogenase as an internal standard. Protein amounts of 11β-OHSD1 and 11β-OHSD2 were assessed by Western blot. The prednisolone/prednisone ratio increased 24 h after UNX in 9 out of 10 animals (P ≤ 0.0011), and was unchanged 14 days after UNX. 11β-OHSD1 oxidation (P ≤ 0.032) and reduction activity (P ≤ 0.002) declined 24 h after UNX in total extracts. 11β-OHSD1 oxidase activity was more than 3 times higher in PCT than in glomeruli, cortical ascending limbs, and CCT, and declined by 50% after UNX (P ≤ 0.001). The reductase activity did not change following UNX in PCT. 11β-OHSD2 activity was 5–15 times higher in CCT than in the other segments, and decreased significantly after UNX (P ≤ 0.008). UNX did not affect messenger RNA and protein levels of both enzymes in total renal extracts. In conclusion, 11β-OHSD1 and 11β-OHSD2 are predominantly expressed in PCT and CCT, respectively, and their corresponding oxidative activities decline after UNX. Thus, the access of 11β-glucocorticosteroids to gluco- and mineralocorticoid receptors in the remaining kidney is facilitated after UNX.</abstract><cop>Washington</cop><pub>Oxford University Press</pub><doi>10.1210/endo.139.4.5891</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0013-7227
ispartof Endocrinology (Philadelphia), 1998-04, Vol.139 (4), p.1533-1539
issn 0013-7227
1945-7170
language eng
recordid cdi_proquest_journals_3130506370
source Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects 11β-Hydroxysteroid dehydrogenase
Dehydrogenase
Dehydrogenases
Enzymes
Glomerulus
Glucocorticoids
Glyceraldehyde
High performance liquid chromatography
Hydroxysteroids
In vivo methods and tests
Kidneys
Limbs
Liquid chromatography
Metabolites
Mineralocorticoid receptors
mRNA
Nephrectomy
Oxidation
Prednisolone
Prednisone
Proteins
Proximal tubules
Receptors
Reductases
Segments
Steroid hormones
Steroids
Tubules
title Reduced 11β-Hydroxysteroid Dehydrogenase Activity in the Remaining Kidney Following Nephrectomy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T12%3A38%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%2011%CE%B2-Hydroxysteroid%20Dehydrogenase%20Activity%20in%20the%20Remaining%20Kidney%20Following%20Nephrectomy&rft.jtitle=Endocrinology%20(Philadelphia)&rft.au=Escher,%20Genevie%CC%80ve&rft.date=1998-04-01&rft.volume=139&rft.issue=4&rft.spage=1533&rft.epage=1539&rft.pages=1533-1539&rft.issn=0013-7227&rft.eissn=1945-7170&rft_id=info:doi/10.1210/endo.139.4.5891&rft_dat=%3Cproquest_cross%3E3130506370%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3130506370&rft_id=info:pmid/&rft_oup_id=10.1210/endo.139.4.5891&rfr_iscdi=true